TrialInternational journal of hematology2022

Bosutinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia: final 3-year follow-up results of a phase 2 study.

Takaaki Ono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.